🇺🇸 FDA

Drug profile · INN

briakinumab

OZESPA

L04AC09
Patents linked
0
News articles
0

Quick answer

briakinumab (OZESPA) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN briakinumab
Brand OZESPA
ATC code L04AC09

Frequently asked questions

What is briakinumab?

briakinumab (OZESPA) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for briakinumab?

OZESPA is a marketed brand name for briakinumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.